AAP releases 2019 child, adolescent vaccination schedules

  • Pediatrics

  • curated by Liz Scherer
  • Clinical Essentials
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • The American Academy of Pediatrics (AAP) has released updated immunization recommendations for children and adolescents in 2019, with several key changes in the following categories: influenza, hepatitis A virus (HAV), tetanus, diphtheria, pertussis (Tdap), Haemophilus influenzae type b, and pneumococcal conjugate vaccines.
  • Schedule revised to ensure consistency with adult recommendations.

Why this matters

  • Familiarity with updated recommendations, including the addition of vaccinations in pregnant adolescents (13-18 years), is essential.
  • A parent-friendly vaccine schedule can help facilitate uptake.

Key points

  • Influenza: live attenuated influenza vaccine is acceptable for children aged >2 years lacking contraindications/as appropriate.
    • Consult newly added “special situations” for guidance on egg allergy.
  • HAV: minimum vaccination age 12 months.
    • Combined HepA/HepB (Twinrix) suitable as 3- or 4-dose series for adolescents aged >18 years.
    • International travel: vaccinate infants aged 6-11 months, unvaccinated infants aged >12 months, first dose before departure.
  • Tdap: Administer routine Tdap dose in children aged 11-12 years if they have received a Tdap or DTaP (diphtheria, tetanus, and pertussis) vaccine inadvertently or as part of a catch-up schedule between ages 7 and 10 years.
  • influenzae type b, pneumococcal conjugate: criteria added regarding routine and catch-up vaccinations, including when doses are needed/unneeded.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit